Mirum Pharmaceuticals Inc... (MIRM)
NASDAQ: MIRM
· Real-Time Price · USD
67.89
3.06 (4.72%)
At close: Aug 15, 2025, 3:59 PM
67.86
-0.04%
After-hours: Aug 15, 2025, 06:59 PM EDT
Mirum Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 228.12M | 211.82M | 222.5M | 222.97M | 233.25M | 302.84M | 286.33M | 303.06M | 297.23M | 49.42M | 28M | 35.76M | 55.27M | 46.27M | 31.34M | 55.84M | 91.94M | 90.68M |
Short-Term Investments | 76.43M | 65.85M | 57.81M | 61.48M | 45.13M | n/a | n/a | 2.97M | 32.73M | 82.65M | 123.72M | 149.59M | 69.69M | 93.64M | 125.2M | 134.19M | 131.91M | 122.44M |
Long-Term Investments | 17.11M | 20.91M | 12.53M | 9.32M | 17.07M | n/a | n/a | n/a | n/a | 100M | 100M | 100M | 100M | 100M | 4.98M | 15M | 14.99M | n/a |
Other Long-Term Assets | 7.32M | 5.9M | 5.81M | 5.8M | 4.22M | 3.87M | 4.17M | 1.51M | 1.15M | 101.34M | 101.38M | 101.71M | 101.72M | 2.03M | 101.79M | 1.64M | 1.43M | 1.43M |
Receivables | 106.84M | 95.85M | 78.29M | 68.53M | 60.43M | 55M | 67.97M | 47.83M | 35.33M | 24.66M | 23.99M | 16.34M | 13.99M | 7.87M | 3.27M | 400K | n/a | n/a |
Inventory | 22.94M | 22.42M | 22.4M | 21.59M | 20.44M | 21.61M | 22.31M | 22.25M | 8.51M | 6.61M | 5.57M | 6.94M | 4.52M | 1.58M | 1.51M | n/a | n/a | n/a |
Other Current Assets | 19.07M | 14.87M | 11.78M | 12.06M | 8.59M | 10.02M | 10.94M | 12.46M | 9.73M | 8.99M | 8.95M | 6.93M | 3.78M | n/a | 5.27M | n/a | 4.51M | 4.64M |
Total Current Assets | 453.4M | 410.82M | 392.79M | 386.63M | 367.83M | 389.46M | 387.54M | 388.58M | 383.52M | 172.33M | 190.22M | 215.56M | 147.25M | 155.27M | 166.59M | 196.81M | 228.37M | 217.75M |
Property-Plant & Equipment | 10.12M | 8.77M | 9.81M | 10.35M | 9.86M | 1.18M | 1.99M | 2.21M | 2.48M | 2.16M | 2.35M | 2.05M | 2.19M | 2.37M | 2.55M | 2.72M | 2.88M | 3.06M |
Goodwill & Intangibles | 237.87M | 243.84M | 249.82M | 255.79M | 261.77M | 257.44M | 252.93M | 258.34M | 56.44M | 57.7M | 58.95M | 45.03M | 46.07M | 18.48M | 18.74M | 19M | n/a | n/a |
Total Long-Term Assets | 272.43M | 279.43M | 277.97M | 281.27M | 292.93M | 262.5M | 259.08M | 262.06M | 60.07M | 161.2M | 162.68M | 148.79M | 149.99M | 122.88M | 128.06M | 38.36M | 19.3M | 4.49M |
Total Assets | 725.83M | 690.25M | 670.75M | 667.89M | 660.75M | 651.96M | 646.62M | 650.64M | 443.59M | 333.53M | 352.91M | 364.35M | 297.23M | 278.15M | 294.65M | 235.17M | 247.67M | 222.24M |
Account Payables | 17.66M | 11.64M | 14.62M | 9.54M | 9.84M | 15.98M | 7.42M | 7.37M | 14.45M | 6.44M | 8.69M | 10.55M | 8.12M | 4.94M | 9.17M | 5M | 5.38M | 5.66M |
Deferred Revenue | n/a | n/a | n/a | n/a | 25.27M | n/a | n/a | 65.13M | n/a | n/a | n/a | n/a | n/a | n/a | 30.72M | 43.85M | 20.77M | 27.78M |
Short-Term Debt | n/a | n/a | n/a | 1.51M | 1.07M | n/a | 1.1M | 1.08M | 1.06M | n/a | n/a | 775K | 752K | 731K | n/a | 690K | 671K | 653K |
Other Current Liabilities | 26.84M | 16.6M | 32.25M | 39.09M | 101.39M | 77.53M | 56.5M | 12.53M | 30.67M | 32.93M | 40.45M | 29.14M | 28.73M | 22.55M | 22.73M | 6.87M | 6.06M | 3.32M |
Total Current Liabilities | 144.8M | 127.58M | 126.55M | 115.75M | 112.31M | 105.91M | 87.06M | 74.66M | 58.2M | 48.84M | 64.73M | 51.4M | 45.17M | 34.55M | 42.6M | 50.39M | 29.03M | 35.02M |
Long-Term Debt | 308.93M | 308.51M | 308.08M | 307.67M | 307.24M | 306.83M | 306.42M | 306.02M | 306.76M | n/a | n/a | 1.31M | 1.52M | 1.71M | n/a | 2.09M | 2.27M | 2.45M |
Other Long-Term Liabilities | 9.05M | 13.9M | 2.51M | 3.97M | 12.22M | 4.29M | 3.85M | 7K | -1.14M | 772K | 4.53M | 141.03M | 138.34M | 131.24M | 129.94M | 124.21M | 118.36M | 48.43M |
Total Long-Term Liabilities | 325.87M | 329.41M | 318.56M | 320.12M | 319.46M | 311.45M | 310.89M | 306.9M | 306.77M | 143.54M | 146.14M | 143.65M | 141.37M | 134.66M | 131.84M | 128.38M | 122.9M | 53.34M |
Total Liabilities | 470.67M | 456.99M | 445.11M | 435.87M | 431.77M | 417.36M | 397.95M | 381.56M | 364.98M | 192.38M | 210.87M | 195.05M | 186.55M | 169.22M | 174.44M | 178.77M | 151.93M | 88.36M |
Total Debt | 318.9M | 317.16M | 317.76M | 317.65M | 316.56M | 307.52M | 308.14M | 306.02M | 307.83M | 1.97M | 2.19M | 2.09M | 2.27M | 2.44M | 2.61M | 2.78M | 2.94M | 3.1M |
Common Stock | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 5K | 4K | 4K | 4K | 4K | 3K | 3K | 3K | 3K | 3K | 3K |
Retained Earnings | -664.72M | -658.86M | -644.18M | -620.39M | -606.16M | -581.52M | -556.24M | -520.58M | -496.99M | -422.95M | -392.82M | -356.39M | -320.69M | -293.76M | -257.16M | -314.7M | -267.6M | -223.7M |
Comprehensive Income | 352K | -258K | -373K | 920K | -477K | -13K | 1.64M | -1.46M | 76K | 136K | -217K | -413K | -202K | -131K | -35K | -6K | -13K | n/a |
Shareholders Equity | 255.16M | 233.26M | 225.64M | 232.02M | 228.99M | 234.6M | 248.67M | 269.08M | -496.99M | 141.15M | -392.82M | 169.3M | 110.69M | 108.93M | 120.21M | 56.4M | 95.74M | 133.88M |
Total Investments | 93.54M | 86.76M | 70.34M | 70.8M | 62.2M | n/a | n/a | 2.97M | 32.73M | 82.65M | 123.72M | 149.59M | 69.69M | 93.64M | 130.18M | 149.19M | 146.9M | 122.44M |